Introduction

Hyperpigmentation disorders such as melasma, post-inflammatory hyperpigmentation (PIH), and sun-induced dark spots are prevalent across skin types, particularly among patients with Fitzpatrick skin types III–VI. Standard treatments often fall short in addressing the multifactorial pathogenesis of pigmentation—ranging from melanocyte hyperactivity and inflammation to vascular involvement.

eNavvi offers a comprehensive suite of customizable compounded skin-lightening creams, providing dermatologists, primary care physicians, and aesthetic providers with high-potency, multi-mechanism options to safely and effectively treat pigmentary disorders.

Pathophysiology of Hyperpigmentation

Hyperpigmentation results from increased melanin production or irregular distribution in the epidermis and/or dermis. It is often triggered by:

• Hormonal changes (e.g., melasma)
• UV radiation
• Inflammation (e.g., acne, eczema, trauma)
• Genetic predisposition

Key treatment goals include:

• Inhibiting tyrosinase activity
• Suppressing melanocyte activation
• Promoting skin turnover
• Addressing vascular and inflammatory contributors

Who Gets Hyperpigmentation?

• Women (especially in melasma and hormonal pigmentation)
• Patients with acne or eczema (prone to PIH)
• Individuals with darker skin tones, who are more susceptible to PIH
• Those with sun exposure or poor sunscreen adherence

Symptoms and Presentation

• Irregular brown or gray patches
• Symmetrical pigmentation (e.g., cheeks, forehead, upper lip)
• Persistent discoloration post-inflammation
• Psychosocial impact and reduced quality of life

Compounded Topicals: Why Choose Custom Formulations?

• Multi-agent synergy for complex pigmentation pathways
• Precise dosing to minimize irritation while maintaining efficacy
• Tailored vehicles for different skin types (dry, oily, sensitive)
• Improved tolerability with customized steroid and retinoid strength

eNavvi's Compounded Whitening Creams: Mechanisms & Use Cases

Here’s a breakdown of commonly used ingredients, mechanisms of action, and when to choose each formulation:

🔹 Hydroquinone (HQ) – 4% to 12%

Mechanism: Inhibits tyrosinase, decreasing melanin synthesis
Use: First-line for epidermal hyperpigmentation
Variants on eNavvi: 5%, 6%, 8%, 10%, and combinations
Cautions: Limit continuous use to 8–12 weeks to avoid ochronosis; cyclic therapy recommended

🔹 Triple Combinations (e.g., Fluocinolone/HQ/Tretinoin/Niacinamide)

Example Formulations:

• 8/0.1/1/4/0.025%
• 4.5/0.025/0.01/4%
• 2.5/10/5/0.01% (Diamond Delux Lite)

Mechanism:

• Hydroquinone: Melanin suppression
• Tretinoin: Increases turnover, enhances HQ penetration
• Fluocinolone/Hydrocortisone: Reduces inflammation and irritation
• Niacinamide: Anti-inflammatory, reduces melanosome transfer

Use: Melasma, PIH, severe pigmentation
Cautions: Titrate steroid exposure to avoid atrophy; ideal for short-term flares

🔹 Tranexamic Acid (TA) – 4% to 8%

Mechanism: Inhibits plasminogen, reducing UV-induced melanocyte activity
Use: Vascular melasma, hormonal pigmentation
eNavvi Formulations:

• TA 5% monotherapy
• TA 8% with Azelaic Acid/Niacinamide

Cautions: Topical TA is generally well tolerated; consider oral TA in resistant cases under specialist care

🔹 Azelaic Acid – 15% to 20%

Mechanism: Tyrosinase inhibitor, anti-inflammatory, keratolytic
Use: PIH, rosacea-associated pigmentation, acne-related dark marks
Formulations: Often combined with TA, Niacinamide, or Kojic Acid
Cautions: Mild irritation possible; titrate slowly for sensitive skin

🔹 Kojic Acid – 3% to 6%

Mechanism: Chelates copper at the active site of tyrosinase
Use: Supportive lightening in combination regimens
Often paired with: HQ, Niacinamide, Ascorbic Acid

🔹 Niacinamide – 2% to 4%

Mechanism: Inhibits melanosome transfer, anti-inflammatory
Use: Maintenance or adjunct therapy to reduce irritation from HQ and retinoids

🔹 Tretinoin – 0.01% to 0.1%

Mechanism: Promotes epidermal turnover, reduces pigment retention
Use: Adjunct to HQ, improves efficacy of lightening agents
Cautions: Irritation, photosensitivity; always recommend sunscreen use

🔹 Ascorbic Acid – 1% to 5%

Mechanism: Antioxidant; neutralizes ROS and reduces melanin formation
Use: Brightening, antioxidant support in long-term regimens

eNavvi Compounding Benefits

• Nationwide Fulfillment in all 50 states
• Transparent Cash Pricing — $35 for 30g, $65 for 60g

Conclusion

Hyperpigmentation requires personalized, multifactorial therapy to address melanocyte activity, inflammation, and skin turnover. eNavvi’s compounded whitening creams offer providers the flexibility to treat a range of pigmentary conditions using combinations that are evidence-based, patient-tolerable, and cost-effective